These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 25533440)

  • 1. A review of uric acid, crystal deposition disease, and gout.
    Perez-Ruiz F; Dalbeth N; Bardin T
    Adv Ther; 2015 Jan; 32(1):31-41. PubMed ID: 25533440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?
    Ruoff G; Edwards NL
    Postgrad Med; 2016 Sep; 128(7):706-15. PubMed ID: 27558643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
    Perez-Ruiz F; Herrero-Beites AM; Carmona L
    Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent approaches to gout drug discovery: an update.
    Otani N; Ouchi M; Kudo H; Tsuruoka S; Hisatome I; Anzai N
    Expert Opin Drug Discov; 2020 Aug; 15(8):943-954. PubMed ID: 32329387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal arthropathies: recognizing and treating "the gouch".
    Quillen DM
    Prim Care; 2010 Dec; 37(4):703-11, v. PubMed ID: 21050952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expert opinion on emerging urate-lowering therapies.
    Stamp LK; Merriman TR; Singh JA
    Expert Opin Emerg Drugs; 2018 Sep; 23(3):201-209. PubMed ID: 30244605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural joint damage in gout.
    Chhana A; Dalbeth N
    Rheum Dis Clin North Am; 2014 May; 40(2):291-309. PubMed ID: 24703348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on gout 2012.
    So A; Busso N
    Joint Bone Spine; 2012 Dec; 79(6):539-43. PubMed ID: 23165182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonography in the diagnosis of asymptomatic hyperuricemia and gout.
    Puig JG; Beltrán LM; Mejía-Chew C; Tevar D; Torres RJ
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):517-523. PubMed ID: 27906639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricaemia and gout.
    Shipley M
    J R Coll Physicians Edinb; 2011 Sep; 41(3):229-33. PubMed ID: 21949921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Febuxostat: a new agent for lowering serum urate.
    Keenan RT; Pillinger MH
    Drugs Today (Barc); 2009 Apr; 45(4):247-60. PubMed ID: 19499090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and Cure of Gouty Arthritis.
    Keller SF; Mandell BF
    Med Clin North Am; 2021 Mar; 105(2):297-310. PubMed ID: 33589104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gout and hyperuricemia.
    Chilappa CS; Aronow WS; Shapiro D; Sperber K; Patel U; Ash JY
    Compr Ther; 2010; 36():3-13. PubMed ID: 21229813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gout: an overview of available urate lowering therapies].
    Richette P
    Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and treatment of gout as a chronic disease.
    Perez-Ruiz F; Herrero-Beites AM
    Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).
    Dalbeth N; Bardin T; Doherty M; Lioté F; Richette P; Saag KG; So AK; Stamp LK; Choi HK; Terkeltaub R
    Nat Rev Rheumatol; 2017 Sep; 13(9):561-568. PubMed ID: 28794514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout.
    Dalbeth N; Merriman T
    Rheumatology (Oxford); 2009 Mar; 48(3):222-6. PubMed ID: 19109320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.